Mucormycosis classification: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 39: | Line 39: | ||
* [[Mycotic]] [[Aneurysm|aneurysms]] | * [[Mycotic]] [[Aneurysm|aneurysms]] | ||
|- | |- | ||
|Pulmonary mucormycosis | |[[Pulmonary]] mucormycosis | ||
| | | | ||
* Most commonly occurs in [[Neutropenia|neutropenic]] and [[stem cell transplant]] patients<sup>[[Mucormycosis classification#cite note-pmid8504272-5|[5]]]</sup> | * Most commonly occurs in [[Neutropenia|neutropenic]] and [[stem cell transplant]] patients<sup>[[Mucormycosis classification#cite note-pmid8504272-5|[5]]]</sup> | ||
| Line 55: | Line 55: | ||
* [[Disseminated disease|Disseminated infection]]<ref name="urlImproved Outcome of Zygomycosis in Patients with Hematological Diseases?: Leukemia & Lymphoma: Vol 45, No 7">{{cite web |url=http://www.tandfonline.com/doi/abs/10.1080/10428190310001653691 |title=Improved Outcome of Zygomycosis in Patients with Hematological Diseases?: Leukemia & Lymphoma: Vol 45, No 7 |format= |work= |accessdate=}}</ref> | * [[Disseminated disease|Disseminated infection]]<ref name="urlImproved Outcome of Zygomycosis in Patients with Hematological Diseases?: Leukemia & Lymphoma: Vol 45, No 7">{{cite web |url=http://www.tandfonline.com/doi/abs/10.1080/10428190310001653691 |title=Improved Outcome of Zygomycosis in Patients with Hematological Diseases?: Leukemia & Lymphoma: Vol 45, No 7 |format= |work= |accessdate=}}</ref> | ||
|- | |- | ||
|Cutaneous mucormycosis | |[[Cutaneous]] mucormycosis | ||
| | | | ||
* Acquired by disruption of the physiologic [[skin]] barrier: | * Acquired by disruption of the physiologic [[skin]] barrier: | ||
| Line 71: | Line 71: | ||
* [[Disseminated disease|Disseminated infection]]<ref name="urlGangrenous Cutaneous Mucormycosis in a Child with a Solid Organ Transplant: A Case Report and Review of the Literature - Boyd - 2003 - Pediatric Dermatology - Wiley Online Library">{{cite web |url=http://onlinelibrary.wiley.com/doi/10.1046/j.1525-1470.2003.20508.x/full |title=Gangrenous Cutaneous Mucormycosis in a Child with a Solid Organ Transplant: A Case Report and Review of the Literature - Boyd - 2003 - Pediatric Dermatology - Wiley Online Library |format= |work= |accessdate=}}</ref> | * [[Disseminated disease|Disseminated infection]]<ref name="urlGangrenous Cutaneous Mucormycosis in a Child with a Solid Organ Transplant: A Case Report and Review of the Literature - Boyd - 2003 - Pediatric Dermatology - Wiley Online Library">{{cite web |url=http://onlinelibrary.wiley.com/doi/10.1046/j.1525-1470.2003.20508.x/full |title=Gangrenous Cutaneous Mucormycosis in a Child with a Solid Organ Transplant: A Case Report and Review of the Literature - Boyd - 2003 - Pediatric Dermatology - Wiley Online Library |format= |work= |accessdate=}}</ref> | ||
|- | |- | ||
|Gastrointestinal mucormycosis | |[[Gastrointestinal]] mucormycosis | ||
| | | | ||
* Rare occurrence | * Rare occurrence | ||
| Line 86: | Line 86: | ||
* [[Disseminated disease|Disseminated infection]] | * [[Disseminated disease|Disseminated infection]] | ||
|- | |- | ||
|Disseminated mucormycosis | |[[Disseminated disease|Disseminated]] mucormycosis | ||
| | | | ||
* Patients on [[Immunosuppressive drug|immunosupressants]] and [[Antifungal drug|anti-fungal]] [[prophylaxis]] (escpecially [[voriconazole]]) are particularly susceptible to [[Disseminated disease|disseminated infection]]<ref name="urlZygomycosis in neutropenic patients with past Aspergillus infection: a role for posaconazole? - Ide - 2004 - Clinical Microbiology and Infection - Wiley Online Library">{{cite web |url=http://onlinelibrary.wiley.com/doi/10.1111/j.1469-0691.2004.00945.x/full |title=Zygomycosis in neutropenic patients with past Aspergillus infection: a role for posaconazole? - Ide - 2004 - Clinical Microbiology and Infection - Wiley Online Library |format= |work= |accessdate=}}</ref><ref name="urlBreakthrough Fungal Infections in Stem Cell Transplant Recipients Receiving Voriconazole | Clinical Infectious Diseases | Oxford Academic">{{cite web |url=https://academic.oup.com/cid/article/39/5/743/364418/Breakthrough-Fungal-Infections-in-Stem-Cell |title=Breakthrough Fungal Infections in Stem Cell Transplant Recipients Receiving Voriconazole | Clinical Infectious Diseases | Oxford Academic |format= |work= |accessdate=}}</ref> | * Patients on [[Immunosuppressive drug|immunosupressants]] and [[Antifungal drug|anti-fungal]] [[prophylaxis]] (escpecially [[voriconazole]]) are particularly susceptible to [[Disseminated disease|disseminated infection]]<ref name="urlZygomycosis in neutropenic patients with past Aspergillus infection: a role for posaconazole? - Ide - 2004 - Clinical Microbiology and Infection - Wiley Online Library">{{cite web |url=http://onlinelibrary.wiley.com/doi/10.1111/j.1469-0691.2004.00945.x/full |title=Zygomycosis in neutropenic patients with past Aspergillus infection: a role for posaconazole? - Ide - 2004 - Clinical Microbiology and Infection - Wiley Online Library |format= |work= |accessdate=}}</ref><ref name="urlBreakthrough Fungal Infections in Stem Cell Transplant Recipients Receiving Voriconazole | Clinical Infectious Diseases | Oxford Academic">{{cite web |url=https://academic.oup.com/cid/article/39/5/743/364418/Breakthrough-Fungal-Infections-in-Stem-Cell |title=Breakthrough Fungal Infections in Stem Cell Transplant Recipients Receiving Voriconazole | Clinical Infectious Diseases | Oxford Academic |format= |work= |accessdate=}}</ref> | ||
Revision as of 01:01, 19 June 2017
|
Mucormycosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Syed Hassan A. Kazmi BSc, MD [2]
Overview
Mucormycosis may be classified according to the organ system involved including brain, lungs, skin, GIT, bones, liver, spleen. Disseminated infection affects multiple organ systems.
Classification
Mucormycosis may be classified based on the organ system involvement as follows:
| Type | Transmission | Signs and Symptoms | Complications |
|---|---|---|---|
| Rhinocerebral mucormycosis |
|
|
|
| Pulmonary mucormycosis |
|
||
| Cutaneous mucormycosis |
|
|
|
| Gastrointestinal mucormycosis |
|
|
|
| Disseminated mucormycosis |
|
|
References
- ↑ "Rhinocerebral mucormycosis: Predisposing factors - Mcnulty - 1982 - The Laryngoscope - Wiley Online Library".
- ↑ "Epidemiology and Outcome of Mould Infections in Hematopoietic Stem Cell Transplant Recipients | Clinical Infectious Diseases | Oxford Academic".
- ↑ Margo CE, Linden C, Strickland-Marmol LB, Denietolis AL, McCaffrey JC, Kirk N (2007). "Rhinocerebral mucormycosis with perineural spread". Ophthal Plast Reconstr Surg. 23 (4): 326–7. doi:10.1097/IOP.0b013e318070855b. PMID 17667114.
- ↑ Hosseini SM, Borghei P (2005). "Rhinocerebral mucormycosis: pathways of spread". Eur Arch Otorhinolaryngol. 262 (11): 932–8. doi:10.1007/s00405-005-0919-0. PMID 15891927.
- ↑ Khor BS, Lee MH, Leu HS, Liu JW (2003). "Rhinocerebral mucormycosis in Taiwan". J Microbiol Immunol Infect. 36 (4): 266–9. PMID 14723256.
- ↑ "Rhinocerebral Mucormycosis: Evolution of the Disease and Treatment Options - Peterson - 1997 - The Laryngoscope - Wiley Online Library".
- ↑ Tedder M, Spratt JA, Anstadt MP, Hegde SS, Tedder SD, Lowe JE (1994). "Pulmonary mucormycosis: results of medical and surgical therapy". Ann. Thorac. Surg. 57 (4): 1044–50. PMID 8166512.
- ↑ "Improved Outcome of Zygomycosis in Patients with Hematological Diseases?: Leukemia & Lymphoma: Vol 45, No 7".
- ↑ "Cutaneous Rhizopus Infection | JAMA | The JAMA Network".
- ↑ "Gangrenous Cutaneous Mucormycosis in a Child with a Solid Organ Transplant: A Case Report and Review of the Literature - Boyd - 2003 - Pediatric Dermatology - Wiley Online Library".
- ↑ "www.nature.com" (PDF).
- ↑ "GASTRIC PERFORATION DUE TO MUCORMYCOSIS AFTER HEART-LUNG AND... : Transplantation".
- ↑ "Zygomycosis in neutropenic patients with past Aspergillus infection: a role for posaconazole? - Ide - 2004 - Clinical Microbiology and Infection - Wiley Online Library".
- ↑ "Breakthrough Fungal Infections in Stem Cell Transplant Recipients Receiving Voriconazole | Clinical Infectious Diseases | Oxford Academic".
- ↑ STRAATSMA BR, ZIMMERMAN LE, GASS JD (1962). "Phycomycosis. A clinicopathologic study of fifty-one cases". Lab. Invest. 11: 963–85. PMID 13984484.